THE EPIDEMIOLOGICAL STATUS OF MYOPIA AS A LEADING REFRACTIVE ERROR

Authors

  • Zorica Iliev University „Goce Delchev“, Republic of North Macedonia
  • Strahil Gazepov University „Goce Delchev“, Republic of North Macedonia

Keywords:

myopia, risk factors, treatment, research

Abstract

In the 21st century, myopia (nearsightedness) has transitioned from a benign refractive anomaly into one of the most significant global public health challenges, reaching epidemic proportions particularly in East Asian regions. According to the standards established by the International Myopia Institute (IMI), it is defined as a condition where the spherical equivalent (SE) is ≤ 0.50 diopters (D), typically resulting from the axial elongation of the eyeball. Current epidemiological models project that by 2050, approximately 5 billion people, or 50% of the global population, will be myopic. Even more concerning is the forecasted increase in high myopia (≤ 6.00 D), which is expected to affect 1 billion people. High myopia is strongly associated with pathological structural changes in the posterior segment, including myopic maculopathy, glaucoma, and retinal detachment, positioning it as a leading cause of irreversible visual impairment. The etiology of myopia is multifactorial, arising from a complex interplay between genetic susceptibility and environmental factors. While genetic risk is substantial (with the risk doubling if one parent is myopic), the rapid escalation in prevalence underscores the dominant role of altered modern lifestyles. Intensive education and "near work" specifically sustained tasks at a distance of less than 30 cm have been identified as potent risk factors. Conversely, time spent outdoors (exceeding 2 hours daily) demonstrates a proven protective effect, likely mediated by light stimulated retinal dopamine release. This paper provides a detailed evaluation of contemporary progression control strategies. Pharmacological interventions, led by low dose atropine (0.05%), exhibit an optimal balance between efficacy and safety. Optical innovations, such as orthokeratology (Ortho K), defocus lenses (DIMS and HAL), and repeated low level red light (RLRL) therapy, offer effective non invasive alternatives for slowing axial growth. A specific focus of this study is directed toward the situation in the Republic of North Macedonia. Due to a chronic lack of national epidemiological data, original research was conducted, encompassing a wide range of respondents. The results reveal a distinct national profile of "late onset" myopia, with diagnoses frequently occurring in young adulthood (ages 19 30). This is strongly correlated with lifestyle: respondents report extreme digital screen exposure (over 8 hours per day) and critically low levels of outdoor activity (less than 2 hours). Furthermore, a low level of awareness regarding alternative treatment methods and irregular ophthalmic examinations were detected. Based on these findings, the paper concludes that the urgent implementation of a national strategy for systematic screening and the promotion of active clinical management is essential to prevent a forthcoming wave of visual impairment within the population.

References

Bao, J., Huang, Y., Li, X., Yang, A., Lim, E. W., Spiegel, D., Drobe, B., & Chen, H. (2022). Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: A randomized clinical trial. JAMA Ophthalmology, 140(5), 472-478;

Dimitrova-Radojichikj, D., & Tasevska, D. (2020). Causes of visual impairment: A retrospective study in Macedonian children. Ophthalmological Journal, 2020(3/494), 29-30;

Dutheil, F., Oueslati, T., Delamarre, L., Castanon, J., Maurin, C., Chiambaretta, F., et al. (2023). Myopia and near work: A systematic review and meta-analysis. International Journal of Environmental Research and Public Health, 20(1), 875;

Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., Wong, T. Y., Naduvilath, T. J., & Resnikoff, S. (2016). Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology, 123(5), 1036-1042;

International Myopia Institute (IMI). (2019). IMI-Defining and classifying myopia: A proposed set of standards for clinical and epidemiologic studies. Investigative Ophthalmology & Visual Science, 60(3), M20-M30;

Kostovska, B., Pluncevikj Gligoroska, J., Gilevska, F., Arnaudovski, Z., & Gabric, N. (2021). First experiences with implantation of phakic lenses in correction of myopia in R. N. Macedonia. Contributions, Section of Medical Sciences, XLII(3), 37-46;

Ljubic, A., Dimitrova, G., Trajkovski, V., Stankovic, B., & Djordjievska, A. (2024). Risk factors in adult myopia in Macedonia. Open Access Macedonian Journal of Medical Sciences, 12(2), 309-313;

Mahmudi, E., Mema, V., Burda, N., Selimi, B., & Zhugli, S. (2013). Incidence of the refractive errors in children 3 to 9 years of age, in the city of Tetovo, Macedonia. Journal of Acute Disease, 2(1), 52-55;

Survey. (2025). Survey regarding myopia prevalence and risk factors in North Macedonia conducted between April 12, 2025 - May 12, 2025 [Unpublished raw data];

Yam, J. C., Zhang, X. J., Zhang, Y., Wang, Y. M., Tang, S. M., Li, F. F., et al. (2022). Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: Continued versus washout: Phase 3 report. Ophthalmology, 129(3), 308-321;

Zheng, Z., Jiang, X., Chen, R., & Dong, L. (2025). Efficacy comparison of atropine, orthokeratology and repeated low-level red-light therapy for myopia control in children: A systematic review and network meta-analysis. British Journal of Ophthalmology, 109(7), 1215-1220.

Downloads

Published

2026-03-24

How to Cite

Iliev, Z., & Gazepov, S. (2026). THE EPIDEMIOLOGICAL STATUS OF MYOPIA AS A LEADING REFRACTIVE ERROR. KNOWLEDGE - International Journal , 75(4), 441–446. Retrieved from https://ojs.ikm.mk/index.php/kij/article/view/8253

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>